Pure Global AI
ANVISA registration 80000230102Valid until Oct 24, 2035

IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS

ANVISA Registration Number: 80000230102AGILENT TECHNOLOGIES BRASIL LTDAAGILENT TECHNOLOGIES, INC.Risk Class III
Device names
Technical name
IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
PT: IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE MAMA
Commercial name
Família de Marcadores de Carcinomas de Mama (Dako Omnis)
Risk class
Class III
Registration details
Registration Number
80000230102
Process Number
25351134900202567
CNPJ
03290250000100
Company information
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Oct 24, 2025
Validity
24/10/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230102 and manufactured by AGILENT TECHNOLOGIES, INC.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Oct 24, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.